Skip to main content
TheraVet SA logo

TheraVet SA — Investor Relations & Filings

Ticker · ALVET ISIN · BE0974387194 LEI · 984500804EBR3F1EFF71 BR Manufacturing
Open in API
Filings indexed 239 across all filing types
Latest filing 2023-10-25 Board/Management Inform…
Country BE Belgium
Listing BR ALVET

About TheraVet SA

https://www.egeiro.com/

TheraVet SA is a veterinary biotechnology company specializing in the development and commercialization of treatments for osteoarticular diseases in companion animals. The company focuses on creating a portfolio of pharmaceutical products and solutions designed to manage bone and joint conditions, such as osteoarthritis. Its primary objective is to provide innovative therapeutic options to improve the mobility and quality of life for pets.

Recent filings

Filing Released Lang Actions
Inside Information / Other news releases
Board/Management Information Classification · 100% confidence The document is a press release announcing the appointment of a new Chief Financial Officer (CFO), Rodolphe Lebrun. This type of announcement details changes in senior management personnel. Based on the provided definitions, the category 'Board/Management Information' (Code: MANG) is the most appropriate classification for announcements regarding changes in the company's senior management.
2023-10-25 English
Informations privilégiées / Autres communiqués
Board/Management Information Classification · 100% confidence The document is a press release dated October 25, 2023, announcing the appointment of a new Chief Financial and Administrative Officer (Directeur Financier et Administratif). This type of announcement, detailing changes in senior management personnel, directly corresponds to the definition of 'Board/Management Information' (MANG). It is not an earnings release (ER), a full annual report (10-K), or a capital raising announcement (CAP), although the new hire's role involves financing strategy.
2023-10-25 French
Inside Information / Other news releases
Regulatory Filings Classification · 90% confidence The document is a press release dated October 18, 2023, detailing commercial successes at veterinary conferences (ESVOT, ACVS) and the official launch of a new product, BIOCERA-VET COMBO-CLEAN, in North America. It discusses business updates, product highlights, and market presence, but it is not a formal regulatory filing like a 10-K, a comprehensive quarterly report (IR), or a specific announcement like a dividend (DIV) or director dealing (DIRS). It functions as an update on business activities and commercial progress, which often falls under general investor relations communication. Since it is not a formal financial report, a transcript, or a specific corporate action notice, the most appropriate category is 'Regulatory Filings' (RNS) as a general announcement, or potentially 'Earnings Release' (ER) if it were tied to a reporting period, but it seems more focused on commercial milestones than financial results highlights. Given the content is a general business update announcing commercial progress and a product launch, and it doesn't fit the specific financial report codes, RNS (Regulatory Filings/General Announcement) is the best fit as a catch-all for non-standard, yet important, company news releases.
2023-10-18 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 100% confidence The document is a press release dated October 18, 2023, detailing commercial participation in veterinary orthopedic conferences (ESVOT, ACVS) and announcing the North American launch of a new product, BIOCERA-VET COMBO-CLEAN. This type of announcement, focusing on business updates, product launches, and participation in industry events, is characteristic of a general corporate update or press release. It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a specific financial report (IR, AR). Since it details significant business developments and product news, it fits best under the general 'Regulatory Filings' (RNS) category as a standard corporate communication, or potentially an Investor Presentation (IP) if it were structured as a deck, but given the format, RNS is the most appropriate fallback for a press release detailing operational and commercial progress that doesn't fit a more specific category like DIV, CAP, or ER.
2023-10-18 French
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 100% confidence The document is a press release dated October 11, 2023, announcing TheraVet's participation in the World Breeding Federation for Sport Horses (WBFSH) annual meeting, where they will present data on their product BIOCERA-VET RTU for treating bone cysts in horses. This type of announcement, detailing corporate activities, product highlights, and participation in industry events, is characteristic of a general corporate update or press release. It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a specific financial report (IR, AR). Since it is a general announcement about company activities and product promotion, and does not fit the specific categories like AGM-R, DIRS, or DIV, the most appropriate classification is the general Regulatory Filings category (RNS), which often serves as a catch-all for non-standard press releases that are still material corporate communications.
2023-10-11 French
Inside Information / Other news releases
Regulatory Filings Classification · 100% confidence The document is a press release dated October 11, 2023, announcing TheraVet's participation and sponsorship at the World Breeding Federation for Sport Horses (WBFSH) annual meeting where they will highlight their product BIOCERA-VET RTU for treating horse bone cysts. This type of announcement, detailing company activities, product highlights, and participation in industry events, is characteristic of general corporate news releases. It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a specific financial report (IR, AR). Since it is a general corporate announcement about business development and product promotion, and it doesn't fit the specific categories like DIRS, DIV, or CAP, it falls best under the general Regulatory Filings (RNS) category, which serves as a broad category for miscellaneous official announcements not covered elsewhere.
2023-10-11 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.